Sagent Pharmaceuticals Issues Voluntary Nationwide Recall Of Docetaxel Injection, USP Due To Potential Presence Of Particulate Matter
SCHAUMBURG, Ill., May 28, 2024 /PRNewswire/ -- Sagent Pharmaceuticals today announced the voluntary nationwide recall of two lots of Docetaxel Inject
Sagent Pharmaceuticals Drug Administration Prnewswire Sagent Pharmaceuticals Docetaxel Injection User Level Expiration Dates
Source: menafn.com